Epidemiology of Gastrointestinal Damage Associated with Nonsteroidal Anti-inflammatory Drugs

Overview

Journal Drug Saf

Specialties Pharmacology
Toxicology

Date 1994 Feb 1

PMID 8011182

Citations 8

Authors

L R Willett

J L Carson

B L Strom

Affiliations

Soon will be listed here.

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with significant upper gastrointestinal (GI) toxicity, with a relative risk of approximately 3. This is supported by evidence drawn from randomised controlled trials [of aspirin (acetylsalicylic acid)], cohort studies and case-control studies. The risk is increased with higher doses of medication, shorter treatment duration and concomitant corticosteroid use. Elderly patients and those with a history of GI illness are also at increased risk. Ibuprofen may be associated with a lower, and piroxicam with a higher, risk of complications. There are only preliminary data regarding an association between NSAIDs and small and large intestinal complications. Therapeutic alternatives which may confer a lower risk of significant GI toxicity include enteric-coated preparations, non-acetylated salicylates, and NSAIDs taken in conjunction with misoprostol. Epidemiological data regarding these alternatives are sparse.

Citing Articles

Endoscopic comparison of gastroduodenal injury with over-the-counter doses of new fast-dissolving ibuprofen and paracetamol formulations: a randomized, placebo-controlled, 4-way crossover clinical trial.

Lanza F, Collaku A, Liu D Clin Exp Gastroenterol. 2018; 11:169-177.

PMID: 29713191 PMC: 5907787. DOI: 10.2147/CEG.S153231.

Diclofenac/misoprostol. Pharmacoeconomic implications of therapy.

Plosker G, Lamb H Pharmacoeconomics. 1999; 16(1):85-98.

PMID: 10539124 DOI: 10.2165/00019053-199916010-00008.

Is aspirin underused in myocardial infarction?.

Arnau J, Agusti A Pharmacoeconomics. 1997; 12(5):524-32.

PMID: 10174319 DOI: 10.2165/00019053-199712050-00003.

Aspirin use and potential mechanisms for colorectal cancer prevention.

Williams C, Smalley W, DuBois R J Clin Invest. 1997; 100(6):1325-9.

PMID: 9294096 PMC: 508309. DOI: 10.1172/JCI119651.

Chirality and nonsteroidal anti-inflammatory drugs.

Hayball P Drugs. 1996; 52 Suppl 5:47-58.

PMID: 8922556 DOI: 10.2165/00003495-199600525-00006.

References

Ehsanullah R, Page M, Tildesley G, Wood J . Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988; 297(6655):1017-21. PMC: 1834765. DOI: 10.1136/bmj.297.6655.1017. View

Mitchell D, Spitz P, Young D, Bloch D, McShane D, Fries J . Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986; 29(6):706-14. DOI: 10.1002/art.1780290602. View

Bradley J, Brandt K, Katz B, Kalasinski L, Ryan S . Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med. 1991; 325(2):87-91. DOI: 10.1056/NEJM199107113250203. View

Allison M, Howatson A, Torrance C, Lee F, Russell R . Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med. 1992; 327(11):749-54. DOI: 10.1056/NEJM199209103271101. View

Beard K, Walker A, Perera D, Jick H . Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med. 1987; 147(9):1621-3. View

Graham D, Smith J, Dobbs S . Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci. 1983; 28(1):1-6. DOI: 10.1007/BF01393353. View

Kaufman D, Kelly J, SHEEHAN J, Laszlo A, Wiholm B, Alfredsson L . Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther. 1993; 53(4):485-94. DOI: 10.1038/clpt.1993.55. View

Guess H, West R, Strand L, Helston D, Lydick E, Bergman U . Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol. 1988; 41(1):35-45. DOI: 10.1016/0895-4356(88)90007-8. View

Armstrong C, Blower A . Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut. 1987; 28(5):527-32. PMC: 1432891. DOI: 10.1136/gut.28.5.527. View

10.

Agrawal N, Roth S, Graham D, White R, Germain B, Brown J . Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med. 1991; 115(3):195-200. DOI: 10.7326/0003-4819-115-3-195. View

11.

Henry D, Johnston A, Dobson A, Duggan J . Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. Br Med J (Clin Res Ed). 1987; 295(6608):1227-9. PMC: 1248302. DOI: 10.1136/bmj.295.6608.1227. View

12.

Griffin M, Piper J, Daugherty J, Snowden M, Ray W . Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991; 114(4):257-63. DOI: 10.7326/0003-4819-114-4-257. View

13.

Carson J, Strom B, Soper K, West S, Morse M . The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med. 1987; 147(1):85-8. View

14.

Gabriel S, Jaakkimainen L, Bombardier C . Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991; 115(10):787-96. DOI: 10.7326/0003-4819-115-10-787. View

15.

Caldwell J, Roth S, Wu W, Semble E, Castell D, Heller M . Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage. Am J Med. 1987; 83(3B):74-82. DOI: 10.1016/0002-9343(87)90832-1. View

16.

Holvoet J, Terriere L, Van Hee W, Verbist L, FIERENS E, Hautekeete M . Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut. 1991; 32(7):730-4. PMC: 1378985. DOI: 10.1136/gut.32.7.730. View

17.

Lanza F, ASPINALL R, Swabb E, Davis R, Rack M, Rubin A . Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology. 1988; 95(2):289-94. DOI: 10.1016/0016-5085(88)90482-9. View

18.

Martio J . The influence of antirheumatic drugs on the occurrence of peptic ulcers. A controlled study of patients with chronic rheumatic diseases. Scand J Rheumatol. 1980; 9(1):55-9. DOI: 10.1080/03009748009098130. View

19.

Carson J, Strom B, Morse M, West S, Soper K, STOLLEY P . The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1987; 147(6):1054-9. View

20.

Graham D, White R, Moreland L, Schubert T, Katz R, Jaszewski R . Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group. Ann Intern Med. 1993; 119(4):257-62. DOI: 10.7326/0003-4819-119-4-199308150-00001. View